Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06422663

A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a Prospective, Observational, Multicentre Study to describe treatment pattern changes of uncontrolled moderate-to-severe asthma patients in China. Sponsor by Astrazeneca Investment(China) Co., LTD.

Official title: A Prospective, Observational, Multicentre Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Key Details

Gender

All

Age Range

12 Years - 130 Years

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2024-03-22

Completion Date

2025-03-13

Last Updated

2026-09-04

Healthy Volunteers

No

Locations (31)

Research Site

Baoding, China

Research Site

Beijing, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Chongqing, China

Research Site

Dingzhou, China

Research Site

Hangzhou, China

Research Site

Harbin, China

Research Site

Hefei, China

Research Site

Hohhot, China

Research Site

Jinan, China

Research Site

Kunming, China

Research Site

Liuzhou, China

Research Site

Lu'an, China

Research Site

Luzhou, China

Research Site

Nanchang, China

Research Site

Nanchong, China

Research Site

Qingdao, China

Research Site

Quanzhou, China

Research Site

Shanghai, China

Research Site

Shenzhen, China

Research Site

Tianjin, China

Research Site

Tiaobingshan, China

Research Site

Wenzhou, China

Research Site

Wuhan, China

Research Site

Xi'an, China

Research Site

Xiamen, China

Research Site

Yongzhou, China

Research Site

Zhangjiagang, China

Research Site

Zhengzhou, China

Research Site

Zigong, China